D-Index & Metrics Best Publications
Microbiology
UK
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 128 Citations 60,066 414 World Ranking 49 National Ranking 7
Medicine D-index 127 Citations 60,583 446 World Ranking 1602 National Ranking 164

Research.com Recognitions

Awards & Achievements

2023 - Research.com Microbiology in United Kingdom Leader Award

2022 - Research.com Microbiology in United Kingdom Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Bacteria
  • Gene

His main research concerns Microbiology, Drug resistance, Antibiotic resistance, Antibacterial agent and Antibiotics. His study in Microbiology is interdisciplinary in nature, drawing from both Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae. His research investigates the link between Drug resistance and topics such as Escherichia coli that cross with problems in Plasmid.

He combines subjects such as Vancomycin, Biotechnology, Methicillin-resistant Staphylococcus aureus and Gene with his study of Antibiotic resistance. His Antibacterial agent research integrates issues from Ceftazidime, Citrobacter freundii, Piperacillin and Genetic transfer. His Antibiotics course of study focuses on Infection control and Carbapenemase-Producing Enterobacteriaceae.

His most cited work include:

  • Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study (2066 citations)
  • beta-Lactamases in laboratory and clinical resistance. (1532 citations)
  • Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare? (1058 citations)

What are the main themes of his work throughout his whole career to date?

David M. Livermore mostly deals with Microbiology, Antibacterial agent, Antibiotics, Drug resistance and Enterobacteriaceae. His Microbiology research is multidisciplinary, incorporating perspectives in Pseudomonas aeruginosa and Klebsiella pneumoniae, Escherichia coli. His research investigates the connection with Antibacterial agent and areas like Ceftazidime which intersect with concerns in Cefotaxime and Piperacillin.

His Antibiotics study combines topics from a wide range of disciplines, such as Internal medicine and Infection control. His Enterobacteriaceae research is multidisciplinary, relying on both Agar dilution, Enterobacter and Bacteria. David M. Livermore has included themes like Tigecycline, Colistin, Carbapenem and Meropenem in his Imipenem study.

He most often published in these fields:

  • Microbiology (90.58%)
  • Antibacterial agent (26.05%)
  • Antibiotics (21.84%)

What were the highlights of his more recent work (between 2016-2021)?

  • Microbiology (90.58%)
  • Agar dilution (17.84%)
  • Pseudomonas aeruginosa (18.44%)

In recent papers he was focusing on the following fields of study:

David M. Livermore mainly investigates Microbiology, Agar dilution, Pseudomonas aeruginosa, Drug resistance and Avibactam. His Microbiology study incorporates themes from Ceftazidime, Enterobacteriaceae and Acinetobacter baumannii. He has researched Agar dilution in several fields, including Penicillin, Carbapenem, Cephalosporin, Acinetobacter and Klebsiella.

The various areas that David M. Livermore examines in his Pseudomonas aeruginosa study include Colistin, Efflux and Strain. His work deals with themes such as Bacterial genetics and Antibiotics, which intersect with Drug resistance. His Antibiotics research incorporates themes from Internal medicine and Escherichia coli.

Between 2016 and 2021, his most popular works were:

  • Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. (270 citations)
  • Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. (270 citations)
  • Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing (171 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Bacteria
  • Gene

His primary areas of investigation include Microbiology, Agar dilution, Klebsiella pneumoniae, Metagenomics and Nanopore sequencing. His Microbiology research is multidisciplinary, incorporating elements of Avibactam, Enterobacteriaceae and Enterobacter. He has researched Enterobacteriaceae in several fields, including Klebsiella and Cefepime.

His Klebsiella pneumoniae research integrates issues from Plasmid, Outbreak, Multilocus sequence typing and Carbapenem. David M. Livermore usually deals with Carbapenem and limits it to topics linked to Infection control and Drug resistance, Antibiotics, Internal medicine, Carbapenemase-Producing Enterobacteriaceae and Pediatrics. David M. Livermore interconnects Gold standard, Polymerase chain reaction and Illumina dye sequencing in the investigation of issues within Metagenomics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

Karthikeyan K. Kumarasamy;Mark Alexander Howard Toleman;Timothy Rutland Walsh;Jay Bagaria.
Lancet Infectious Diseases (2010)

3703 Citations

beta-Lactamases in laboratory and clinical resistance.

David M. Livermore.
Clinical Microbiology Reviews (1995)

2516 Citations

Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?

David M. Livermore.
Clinical Infectious Diseases (2002)

1767 Citations

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber.
Lancet Infectious Diseases (2013)

1547 Citations

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study

Timothy Rutland Walsh;Timothy Rutland Walsh;Janis Lesley Weeks;David M. Livermore;Mark Alexander Howard Toleman.
Lancet Infectious Diseases (2011)

1328 Citations

Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Neil Woodford;Matthew J. Ellington;Juliana M. Coelho;Jane F. Turton.
International Journal of Antimicrobial Agents (2006)

1234 Citations

CTX-M: changing the face of ESBLs in Europe

David M. Livermore;Rafael Canton;Marek Gniadkowski;Patrice Nordmann.
Journal of Antimicrobial Chemotherapy (2006)

1202 Citations

Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance

Neil Woodford;Jane F. Turton;David M. Livermore.
Fems Microbiology Reviews (2011)

976 Citations

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

R. Cantón;M. Akóva;Y. Carmeli;C.G. Giske.
Clinical Microbiology and Infection (2012)

960 Citations

The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii

Jane F. Turton;M. Elaina Ward;Neil Woodford;Mary E. Kaufmann.
Fems Microbiology Letters (2006)

876 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David M. Livermore

Patrice Nordmann

Patrice Nordmann

University of Fribourg

Publications: 319

Laurent Poirel

Laurent Poirel

University of Fribourg

Publications: 255

Robert A. Bonomo

Robert A. Bonomo

Case Western Reserve University

Publications: 214

Gian Maria Rossolini

Gian Maria Rossolini

University of Florence

Publications: 202

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 188

David L. Paterson

David L. Paterson

University of Queensland

Publications: 160

Antonio Oliver

Antonio Oliver

Instituto de Salud Carlos III

Publications: 136

Rafael Cantón

Rafael Cantón

Instituto Ramón y Cajal de Investigación Sanitaria

Publications: 126

Timothy R. Walsh

Timothy R. Walsh

University of Oxford

Publications: 117

Thierry Naas

Thierry Naas

University of Paris-Saclay

Publications: 104

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 104

Yohei Doi

Yohei Doi

University of Pittsburgh

Publications: 104

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 100

James A. Karlowsky

James A. Karlowsky

University of Manitoba

Publications: 98

Kyungwon Lee

Kyungwon Lee

Yonsei University

Publications: 97

Yehuda Carmeli

Yehuda Carmeli

Tel Aviv University

Publications: 95

Trending Scientists

Anthony J. Weiss

Anthony J. Weiss

Tel Aviv University

Martin W. Liebeck

Martin W. Liebeck

Imperial College London

Weiyao Lin

Weiyao Lin

Shanghai Jiao Tong University

Neil Hewitt

Neil Hewitt

University of Ulster

John P. Robinson

John P. Robinson

University of Nottingham

Rickard Sandberg

Rickard Sandberg

Karolinska Institute

Jun Qin

Jun Qin

Baylor College of Medicine

James M. Pipas

James M. Pipas

University of Pittsburgh

Jason E. Gestwicki

Jason E. Gestwicki

University of California, San Francisco

Alan O Trounson

Alan O Trounson

Monash University

Jian-Yong Wu

Jian-Yong Wu

Hong Kong Polytechnic University

Robert F. Grant

Robert F. Grant

University of Alberta

Thierry Roger

Thierry Roger

University of Lausanne

Sylviane Muller

Sylviane Muller

University of Strasbourg

Roberto Dell'Acqua

Roberto Dell'Acqua

University of Padua

Gregory J. Seymour

Gregory J. Seymour

University of Queensland

Something went wrong. Please try again later.